Paul St. Romain

Dr. Paul St. Romain

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2018 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
PRPaul St. Romain
Paul St. Romain
ABAmanda Boyd
Amanda Boyd
JZJiayin Zheng
Jiayin Zheng
Shein-Chung ChowShein-Chung Chow
Shein-Chung Chow
RBRebecca Burbridge
Rebecca Burbridge
DWDaniel Wild
Daniel Wild
Introduction and study aims Gastric antral vascular ectasia (GAVE) is a mucosal abnormality associated with multiple conditions, most notably cirrhosis and systemic sclerosis, that causes indolent gastrointestinal bleeding. It is primarily managed with endoscopic therapy. Traditionally, GAVE is endoscopically ablated using argon plasma coagulation (APC) but radiofrequency ablation (RFA) is emerging as an alternative modality. No prior comparison of the 2 modalities has been published. We retrospectively compared the effects of GAVE ablation with either RFA, APC or both in the largest cohort of patients thus far presented. We also attempt to discern what effect concomitant cirrhosis has on response to treatment. Patients and methods After receiving IRB approval, we reviewed our electronic health records to identify all patients who underwent endoscopic evaluation for GAVE between January, 2011 and October, 2016. We compared important variables between APC and RFA, as well as between cirrhosis and non-cirrhosis, using the Chi-square test and the Wilcoxon two-sample test as appropriate. Results During our study period, 81 patients were endoscopically evaluated for GAVE. 24 patients were treated with APC alone, 28 with RFA alone and 25 patients received both treatment modalities. APC-treated patients underwent a mean of 2.4 treatment sessions with a mean of 205 days between treatments. RFA-treated patients underwent a mean of 2.3 treatment sessions with a mean of 100 days between treatments. Hemoglobin values remained stable or increased in all patients during our study period and there were no significant differences in Hgb trend between those treated with APC and those with RFA. Conclusions RFA and APC were both effective in treating bleeding from GAVE. Though we found subtle differences, patients underwent a similar number of treatment sessions and had similar procedure times and a similar time between sessions no matter the treatment modality used.

1 May 2018 in Gastroenterology
Verified
Journal Article
Closed access
PRPaul St. Romain
Paul St. Romain
RWRichard K. Wood
Richard K. Wood
RBRebecca A. Burbridge
Rebecca A. Burbridge
APAmit Patel
Amit Patel
DLDavid A. Leiman
David A. Leiman
RSRahul A. Shimpi
Rahul A. Shimpi